These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21254451)

  • 41. Integration of the Forensic Dimension into Anti-Doping Strategies.
    Marclay F; Saugy M
    Med Sport Sci; 2017; 62():129-138. PubMed ID: 28571028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LC-MS-MS analysis of dietary supplements for N-ethyl-α-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine.
    ElSohly MA; Gul W
    J Anal Toxicol; 2014 Mar; 38(2):63-72. PubMed ID: 24344073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concerning the viewpoint; "An anti-doping sampling strategy utilizing the sewerage systems of sport villages".
    Harman C; Reid M; Thomas KV
    Environ Sci Technol; 2011 May; 45(10):4191; author reply 4192. PubMed ID: 21500825
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent developments in drug abuse and doping control in sport.
    Radford PF
    J R Coll Surg Edinb; 1990 Dec; 35(6 Suppl):S2-6. PubMed ID: 2079694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 33rd Manfred Donike Workshop on Doping Analysis.
    Thevis M
    Drug Test Anal; 2015; 7(11-12):971-2. PubMed ID: 26607559
    [No Abstract]   [Full Text] [Related]  

  • 47. The 29th Manfred Donike workshop on doping analysis.
    Hemmersbach P
    Drug Test Anal; 2011; 3(11-12):755. PubMed ID: 22213683
    [No Abstract]   [Full Text] [Related]  

  • 48. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breaking Boundaries: Exploring Performance Enhancement and Anti-Doping Testing in Sports.
    Metushi IG; Wagner A; Ahrens B; Ericsson M; Rabin O; Sobolevsky T; Tygart TT
    Clin Chem; 2024 Jul; 70(7):897-904. PubMed ID: 38965701
    [No Abstract]   [Full Text] [Related]  

  • 50. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
    Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
    Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
    [No Abstract]   [Full Text] [Related]  

  • 51. The detection of doping by means of chromatographic methods. 1966.
    Donike M
    Drug Test Anal; 2011 Jan; 3(1):15-7. PubMed ID: 21254452
    [No Abstract]   [Full Text] [Related]  

  • 52. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances.
    Barroso O; Miller J; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 34
    Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1108. PubMed ID: 27732762
    [No Abstract]   [Full Text] [Related]  

  • 54. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution.
    Oleksak P; Nepovimova E; Valko M; Alwasel S; Alomar S; Kuca K
    Environ Toxicol Pharmacol; 2024 Jun; 108():104447. PubMed ID: 38636744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The analytical challenges of anti-doping analysis.
    Harrison CR
    Anal Bioanal Chem; 2013 Dec; 405(30):9615-6. PubMed ID: 24043378
    [No Abstract]   [Full Text] [Related]  

  • 56. An anti-doping sampling strategy utilizing the sewerage systems of sport villages.
    Katsoyiannis A; Jones KC
    Environ Sci Technol; 2011 Jan; 45(2):362-3. PubMed ID: 21142144
    [No Abstract]   [Full Text] [Related]  

  • 57. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
    Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.